Emerging drugs for the treatment of benign prostatic obstruction

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.15, Iss.2, 2010-06, pp. : 159-174

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia

Current Medicinal Chemistry, Vol. 13, Iss. 28, 2006-12 ,pp. : 3395-3416

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment options for benign prostatic hyperplasia

By Thurlow R.J.

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 225-246

Informa Healthcare

Access to resources Recommend Favorite

Dutasteride for the treatment of benign prostatic hyperplasia

By Wu Christopher Kapoor Anil

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. : 1399-1408

Informa Healthcare

Access to resources Recommend Favorite

Emerging drug therapies for benign prostatic hyperplasia

By Bullock Travis L Andriole Jr Gerald L

Expert Opinion on Emerging Drugs, Vol. 11, Iss. 1, 2006-03 ,pp. : 111-123

Informa Healthcare

Access to resources Recommend Favorite

NX 1207 is promising for the treatment of benign prostatic hyperplasia

Inpharma, Vol. 1, Iss. 1617, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite